Juan A. Díaz-González

Author

Also Known As

J A Diaz-Gonzalez, J Diaz-Gonzalez, J González, J. A. Diaz-Gonzalez, J. Diaz-Gonzalez, J. Diaz-gonzalez, J. Díaz-Gonzalez, J.A. Diaz-Gonzalez, J.A. Diaz-González, J.A. Díaz-González

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Universidad de Navarra Clinica Universidad de Navarra Hospital General Universitario Gregorio Marañón Memorial Sloan Kettering Cancer Center

About

Juan A. Díaz-González is an author at Universidad de Navarra specializing in oncology, medicine, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	11	455
2	Health Sciences	4	4	93
3	Biochemistry	1	1	42
4	Gastroenterology	1	1	20
5	Pathology	1	1	42

Juan A. Díaz-González

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
microRNA-451 Regulates Macrophage Migration Inhibitory Factor Production and Proliferation of Gastrointestinal Cancer Cells Eva Bandrés, Nerea Bitarte, Fernando Arias, Clinical Cancer Research	2009	346
cT3N0 Rectal Cancer: Potential Overtreatment With Preoperative Chemoradiotherapy Is Warranted José G. Guillem, Juan A. Díaz-González, Bruce D. Minsky, Journal of Clinical Oncology	2008	264
Antitumor and antiangiogenic effect of the dual EGFR and HER-2 tyrosine kinase inhibitor lapatinib in a lung cancer model Roque Díaz, Paul Nguewa, Ricardo Parrondo, BMC Cancer	2010	85
Improved incidence of pT0 downstaged surgical specimens in locally advanced rectal cancer (LARC) treated with induction oxaliplatin plus 5-fluorouracil and preoperative chemoradiation Felipe A. Calvo, Javier Serrano, Juan A. Díaz-González, Annals of Oncology Surgical OncologyRadiation TherapyGastrointestinal OncologyMedicineSurgical Specimens	2006	83
Prognostic factors for disease-free survival in patients with T3–4 or N+ rectal cancer treated with preoperative chemoradiation therapy, surgery, and intraoperative irradiation Juan A. Díaz-González, Felipe A. Calvo, Javier Cortés, International Journal of Radiation OncologyBiologyPhysics Prognostic FactorsSurgical OncologyRadiation TherapyGastrointestinal OncologyColorectal Surgery	2006	73
Intraoperative presacral electron boost following preoperative chemoradiation in T3–4Nx rectal cancer: initial local effects and clinical outcome analysis Felipe A. Calvo, Juan A. Díaz-González, Arnaldo Ríos Alvarado, Radiotherapy and Oncology Surgical OncologyRadiation TherapyMedicineInitial Local EffectsPreoperative Chemoradiation	2002	63
The novel Akt inhibitor Palomid 529 (P529) enhances the effect of radiotherapy in prostate cancer Roque Díaz, Paul Nguewa, Juan A. Díaz-González, British Journal of Cancer	2009	53
Role of histological regression grade after two neoadjuvant approaches with or without radiotherapy in locally advanced gastric cancer P. Martin Romano, J. Solà, Juan A. Díaz-González, British Journal of Cancer	2016	48
Detecting changes in tumor hypoxia with carbonic anhydrase IX and pimonidazole Kyung Hwan Shin, Juan A. Díaz-González, James Russell, Cancer Biology & Therapy Chemoprevention StrategyCancer BiologyRedox BiologyTumor BiologyOxidative Stress	2007	42
Pathologic downstaging of T3–4Nx rectal cancer after chemoradiation: 5-fluorouracil vs. Tegafur Felipe A. Calvo, Juan A. Díaz-González, Rocı́o Cantalapiedra, International Journal of Radiation OncologyBiologyPhysics 5-Fluorouracil Vs. TegafurRadiation TherapyGastrointestinal OncologyMedicineCancer Recurrence	2001	42

Page 1